BridgeBio has significantly advanced its course of a new treatment for amyloid heart disease, utilizing Attruby. Early trial information suggests significant benefits for individuals affected from the debilitating https://bridgebio853247.ampblogs.com/firm-progresses-cardiac-amyloidosis-management-with-the-therapy-79093575